Skip to main content

Advertisement

Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: Antiproliferation of Cryptocarya concinna-derived cryptocaryone against oral cancer cells involving apoptosis, oxidative stress, and DNA damage

Fig. 2

The sub-G1 accumulations of CPC-treated oral cancer Ca9-22 cells and the effect of NAC pretreatment. With or without 2 mM NAC pretreatment for 1 h, Ca9-22 cells were treated with 0, 3, 6, 9, and 12 μM of CPC for 24 h. a Representative flow cytometry-based cell cycle distribution profiles of CPC-treated Ca9-22 cells. The cell cycle phases are underlined in each panel. b Quantification analysis for the subG1 percentages in Fig. 2a. Data, mean ± SD (n = 3). For the same drug treatment of different concentrations, data marks (a to d) without overlapping by the same lower-case letter significantly differed (one-way ANOVA with Tukey HSD Post Hoc Test)

Back to article page